{
    "clinical_study": {
        "@rank": "158073", 
        "acronym": "N-PhenoGENICS", 
        "arm_group": [
            {
                "arm_group_label": "Case", 
                "description": "Leukemia survivors with TRANCE trait"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "Leukemia survivors without TRANCE trait"
            }
        ], 
        "biospec_descr": {
            "textblock": "DNA samples obtained via blood, saliva and buccal sample collection."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "To find possible therapeutic targets to help prevent long-term brain and behavioural side\n      effects in survivors of childhood leukemia that may have been caused by chemotherapy\n      (Treatment-Related late Adverse Neuro-Cognitive Effects: TRANCE). The study hypothesis is\n      that genetic variations of the elements in the folate-related cycles and methotrexate\n      disposition networks are associated with the TRANCE phenotype of childhood leukemia\n      survivors."
        }, 
        "brief_title": "N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors", 
        "condition": "Childhood Leukemia Survivors", 
        "condition_browse": {
            "mesh_term": "Leukemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Past diagnosis of acute lymphoblastic leukemia\n\n          -  8 years : 0 months - 18 years : 11 months old at the time of their study visit\n\n          -  2 years : 0 months - 10 years : 11 months from the last treatment for acute\n             lymphoblastic leukemia at the time of their study visit\n\n          -  Continuous complete remission and undergone no bone marrow transplantation\n\n          -  Fluent in English (a subject and one parent) for test completion\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  Inability to complete the phenotyping tests\n\n          -  Down Syndrome diagnosis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "8 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Childhood leukemia survivors"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913093", 
            "org_study_id": "1000033923"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Childhood leukemia survivors", 
            "Acute lymphoblastic leukemia", 
            "Leukemia", 
            "Late effects", 
            "Folate", 
            "Blood folate", 
            "Neurotoxicity", 
            "Methotrexate", 
            "Pharmacogenetics", 
            "Cognitive", 
            "Cognitive late effects", 
            "N-PhenoGENICS"
        ], 
        "lastchanged_date": "November 29, 2013", 
        "location": {
            "contact": {
                "email": "michelle.vitti@sickkids.ca", 
                "last_name": "Vitti", 
                "phone": "416-813-8285"
            }, 
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario"
                }, 
                "name": "The Hospital for Sick Children"
            }, 
            "investigator": {
                "last_name": "Dr. Shinya Ito", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "2", 
        "official_title": "N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors", 
        "other_outcome": {
            "measure": "To identify DNA methylation patterns associated with TRANCE trait in the leukemia survivors", 
            "safety_issue": "No", 
            "time_frame": "100 participants in 5 years"
        }, 
        "overall_contact": {
            "email": "michelle.vitti@sickkids.ca", 
            "last_name": "Michelle Vitti", 
            "phone": "416-813-8285"
        }, 
        "overall_official": [
            {
                "affiliation": "The Hospital for Sick Children", 
                "last_name": "Dr. Shinya Ito", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Hospital for Sick Children", 
                "last_name": "Dr. Sharon Guger", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Hospital for Sick Children", 
                "last_name": "Dr. Johann Hitzler", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Hospital for Sick Children", 
                "last_name": "Dr. Deborah L O'Connor", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Hospital for Sick Children", 
                "last_name": "Dr. Russell Schachar", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Hospital for Sick Children", 
                "last_name": "Dr. Brenda Spiegler", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Hospital for Sick Children", 
                "last_name": "Dr. Rosanna Weksberg", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "To define neuro-cognitive/behavioural phenotypes of the childhood leukemia survivors", 
            "safety_issue": "No", 
            "time_frame": "100 participants assessed/year for 5 years."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913093"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Hospital for Sick Children", 
            "investigator_full_name": "Shinya Ito", 
            "investigator_title": "Division Head, Clinical Pharmacology and Toxicology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "To characterize the folate and vitamin B12 intakes of these children.", 
            "safety_issue": "No", 
            "time_frame": "<100 participants assessed/year for 5 years"
        }, 
        "source": "The Hospital for Sick Children", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Canadian Institutes of Health Research  (CIHR)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Canadian Cancer Society Research Institute (CCSRI)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "C17 Council", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Garron Family Cancer Center at the Hospital for Sick Children", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Pediatric Oncology Group of Ontario", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "The Hospital for Sick Children", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}